![Hiroshi Nagashima](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hiroshi Nagashima
Director Técnico/Científico/I+D en PorMedTec Co., Ltd. .
Cargos activos de Hiroshi Nagashima
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PorMedTec Co., Ltd.
![]() PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Director/Miembro de la Junta | 01/09/2020 | - |
Director Técnico/Científico/I+D | 01/09/2020 | - |
Historial de carrera de Hiroshi Nagashima
Estadísticas
Internacional
Japón | 2 |
Operativa
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
PorMedTec Co., Ltd.
![]() PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Health Technology |
- Bolsa de valores
- Insiders
- Hiroshi Nagashima
- Experiencia